Showing results (1501-1510 of 1,788) with videos related to
Sort By:
Pageof 179
Journal of Neuroimmunology|December 6, 2021
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancerMichelle C Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.Frontiers in Pediatrics|November 25, 2021
Predicting Flow Rate Escalation for Pediatric Patients on High Flow Nasal Cannula Using Machine LearningJoshua A Krachman, Jessica A Patricoski, Christopher T Le, et al.Prehospital Emergency Care|August 18, 2018
Assessment of Key Health and Wellness Indicators Among North Carolina Emergency Medical Service ProvidersJane H Brice, Julianne M Cyr, Andrew T Hnat, et al.Nature Neuroscience|August 1, 2017
Necroptosis activation in Alzheimer's diseaseAntonella Caccamo, Caterina Branca, Ignazio S Piras, et al.Nature Communications|December 14, 2017
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicityIan P Winters, Shin-Heng Chiou, Nicole K Paulk, et al.Journal of Surgical Oncology|January 11, 2026
Insulin-Dependence and Survival in Pancreatic Neuroendocrine Tumors: Results From the US-NTSG GroupMuhammad Bilal Mirza, Jordan J Baechle, Paula Marincola Smith, et al.Critical Care Explorations|March 26, 2025
Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning ScoreMatthew M Churpek, Kyle A Carey, Ashley Snyder, et al.Prehospital Emergency Care|May 7, 2024
Does Single Dose Epinephrine Improve Outcomes for Patients with Out-of-Hospital Cardiac Arrest and Bystander CPR or a Shockable Rhythm?Tyler S George, Nicklaus P Ashburn, Anna C Snavely, et al.AIDS (London, England)|June 3, 2009
Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes studyJames A McKinnell, Hui-Yi Lin, Christa N Nevin, et al.Antiviral Research|April 20, 2006
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinDale L Barnard, Craig W Day, Kevin Bailey, et al.Pageof 179